RI H7118

State Board of Pharmacy must annually identify up to 15 prescription drugs on which Rhode Island spends significant healthcare dollars and where wholesale acquisition cost increased by 50% or more over 5 years or 15% or more over 12 months

Attorney General will require manufacturers of identified drugs to justify price increases, with civil penalties up to $10,000 per violation for failure to provide required information

Insurance Commissioner must adopt rules by January 1, 2027 requiring health insurers on HealthSource RI to provide searchable, standardized online formulary information including covered drugs, cost-sharing, and prior authorization requirements

Department of Health must use the same dispensing fee for 340B prescription drugs as non-340B drugs under Medicaid, and report to the legislature by March 15, 2027 on 340B reimbursement recommendations

Advisory commission will be convened to develop health benefit plan options for the 2028 plan year with varying out-of-pocket prescription drug limits, including representatives from insurers, AIDS services organizations, and the American Cancer Society